Research News and Research

RSS

NIH awards $1.4 million Small Business Technology Transfer grant to BloodCenter of Wisconsin

BloodCenter of Wisconsin (BCW) today announced that the National Institutes of Health (NIH) has awarded a $1.4 million Small Business Technology Transfer grant to fund continued research into the deployment of Radio Frequency Identification (RFID) technology to enhance safety and reduce hospital costs related to the collection, manufacture and transfusion of blood products. The NIH grant allows the first-ever research into the potential clinical and financial benefits of RFID technology for automatic identification, tracking, and status monitoring of blood and blood products across the entire transfusion medicine supply chain.

24 Oct 2009

University neurologists launch multiple sclerosis research study

Neurologists at the University at Buffalo are beginning a research study that could overturn the prevailing wisdom on the cause of multiple sclerosis (MS).

24 Oct 2009

Columbia Laboratories to raise funds through sale of its common stock and warrants

Columbia Laboratories, Inc. today announced that it has priced a transaction to raise up to approximately $11,772,000 through the sale of up to approximately 10,900,000 shares of its common stock and warrants to purchase 5,450,000 shares of its common stock in a registered direct offering. The common stock and warrants will be sold in units, with each unit consisting of one share of common stock and a warrant to purchase 0.5 shares of common stock.

24 Oct 2009

Updated data on XL184 study in patients with glioblastoma multiforme presented

Exelixis, Inc. and Bristol-Myers Squibb Company today reported updated phase 2 clinical data which show that XL184 demonstrated activity in patients with glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer.

24 Oct 2009

TransMolecular announces final results from its Phase 2 clinical study of 131I-TM601

TransMolecular, Inc., a developer of innovative oncology drugs through targeted delivery technologies, today announced final results from its Phase 2 clinical study comparing the toxicity and overall survival of three versus six intracavitary injections of its anti-cancer compound 131I-TM601 in the treatment of recurrent malignant glioma.

24 Oct 2009

Study links urogenital birth defects with DDT

Women who lived in villages sprayed with DDT to reduce malaria gave birth to 33 per cent more baby boys with urogenital birth defects (UGBD) between 2004 and 2006 than women in unsprayed villages, according to research published online by the UK-based urology journal BJUI.

24 Oct 2009

Low adiponectin levels may increase sepsis related complications

A new Canadian study has found that lower-than-normal levels of a naturally-occurring fat hormone may increase the risk of death from sepsis-an overwhelming infection of the blood which claims thousands of lives each year.

24 Oct 2009

PPA reaches historic milestone; helps the six millionth person

After visiting more than 3,000 cities in all 50 states, the Partnership for Prescription Assistance (PPA) has reached a historic milestone today by helping the six millionth person at an event in Harrisburg, Pennsylvania.

24 Oct 2009

Cohen Independent Research Group publishes a report profiling Nutra Pharma

Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that Cohen Independent Research Group has published a report profiling Nutra Pharma Corporation.

24 Oct 2009

2009 Inspiration Gala raises $1.27 million for BC Cancer Foundation

The 2009 Inspiration Gala raised $1.27 million for the BC Cancer Foundation and colorectal cancer research at the BC Cancer Agency last night, as nearly 400 guests dined and donated during the emotion-filled, sold-out event.

24 Oct 2009

U.S. District Court rules in favor of Allergan in its patent infringement suit against Exela PharmSci

Allergan, Inc. announced today that the United States District Court for the District of Delaware ruled in favor of Allergan, Inc. in its patent infringement suit against Exela PharmSci, Inc., Exela PharmSci Pvt., Ltd. ("Exela"), Apotex, Inc. and Apotex Corp. ("Apotex") (collectively, the "Defendants") for seeking to market purported generic versions of Allergan’s drugs ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.1% and 0.15%. Specifically, after a trial in March of 2009, the Court ruled today that all five patents (U.S. Patent Nos. 6,627,210; 6,641,834; 6,673,337; 6,562,873; and 5,424,078) asserted by Allergan are valid and enforceable, that Apotex's proposed generic versions of ALPHAGAN® P 0.1% and 0.15% infringe each of the five patents, and that Exela's proposed generic version of ALPHAGAN® P 0.15% infringes U.S. Patent No. 6,641,834, which was the only patent asserted against it. Pursuant to the Hatch-Waxman Act, the United States Food and Drug Administration is required to delay approval of Defendants’ proposed generic products until the last to expire of the infringed patents, which is 2022.

24 Oct 2009

Bio-Rad Laboratories to acquire diagnostic businesses of Biotest AG for 45 million euros

Bio-Rad Laboratories, Inc., a multinational manufacturer and distributor of life science research and clinical diagnostics products, announced today that it has signed an agreement to acquire certain diagnostic businesses of Biotest AG for 45 million euros.

24 Oct 2009

HHS funds $17M for fight against costly and dangerous health care-associated infections

HHS Secretary Kathleen Sebelius today announced the award of $17 million to fund projects to fight costly and dangerous health care-associated infections, or HAIs.

24 Oct 2009

New Living 4 Life wellness program to make life better for seniors

Aegis Living, a national leader in senior living and assisted living communities, is pleased to announce that it's partnering with Bastyr University, renowned institution of natural health arts and sciences education and research, to make life better for seniors through its new innovative Living 4 Life program. With this collaboration, new programs and activities will enhance the mind, spirit and physical health of residents at Aegis Living.

24 Oct 2009

One in 10 adolescents exhibit chronic behavior problems

Ten percent of young adolescent boys -- or one in 10 -- exhibit a symptom of conduct disorder as well as a symptom of risky or problem gambling, according to new research findings from the University at Buffalo's Research Institute on Addictions (RIA).

24 Oct 2009

Sickle cell disease can be treated with resveratrol extract, according to researchers

An extract in red grape skin may be a new treatment for sickle cell disease, Medical College of Georgia researchers say.

23 Oct 2009

Ontario Health Coalition names recipients of the Dan Benedict, Ethel Meade and Volunteer Awards

Each year the Ontario Health Coalition gives awards to those who have made an exceptional contribution to the protection of public health care.

23 Oct 2009

EnteroMedics reports financial results for 2009 third quarter

EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, today reported financial results for the three and nine months ended September 30, 2009.

23 Oct 2009

Physicians' recognize benefits of genetic testing; say formal education required to put it into practice

Medco Health Solutions, Inc.(NYSE: MHS) and the American Medical Association (AMA) today announced the findings of a national benchmark survey on physicians' acceptance, use and education regarding pharmacogenomic testing.

23 Oct 2009

Bend Research looking for partners to develop oligonucleotide delivery technologies

Bend Research Inc., a company with more than 30 years of experience in applying innovative pharmaceutical technologies to help clients solve their most difficult scientific and technical problems, is marking the one-year anniversary of a new initiative focused on meeting the needs of a broad range of U.S. and international clients.

23 Oct 2009

Research News and Research

NIH awards $1.4 million Small Business Technology Transfer grant to BloodCenter of Wisconsin

University neurologists launch multiple sclerosis research study

Columbia Laboratories to raise funds through sale of its common stock and warrants

Updated data on XL184 study in patients with glioblastoma multiforme presented

TransMolecular announces final results from its Phase 2 clinical study of 131I-TM601

Study links urogenital birth defects with DDT

Low adiponectin levels may increase sepsis related complications

PPA reaches historic milestone; helps the six millionth person

Cohen Independent Research Group publishes a report profiling Nutra Pharma

2009 Inspiration Gala raises $1.27 million for BC Cancer Foundation

U.S. District Court rules in favor of Allergan in its patent infringement suit against Exela PharmSci

Bio-Rad Laboratories to acquire diagnostic businesses of Biotest AG for 45 million euros

HHS funds $17M for fight against costly and dangerous health care-associated infections

New Living 4 Life wellness program to make life better for seniors

One in 10 adolescents exhibit chronic behavior problems

Sickle cell disease can be treated with resveratrol extract, according to researchers

Ontario Health Coalition names recipients of the Dan Benedict, Ethel Meade and Volunteer Awards

EnteroMedics reports financial results for 2009 third quarter

Physicians' recognize benefits of genetic testing; say formal education required to put it into practice

Bend Research looking for partners to develop oligonucleotide delivery technologies

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News